Security key
98937L105
Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO)
CUSIP: 98937L105
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 63,278,585
- Total 13F shares
- 31,699,756
- Share change
- +2,957,105
- Total reported value
- $259,632,936
- Price per share
- $8.19
- Number of holders
- 65
- Value change
- +$20,083,837
- Number of buys
- 42
- Number of sells
- 21
Report period
Q4 2024
Institutions
65
Top holders
10
ZBIO full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Zenas BioPharma, Inc. SEC filings
Zenas BioPharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98937L105
Recent filing periods:
Top shareholders of ZBIO - Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
7.8%
|
4,911,539
|
$83,103,240 | — | 30 Sep 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
4.1%
|
2,613,948
|
$44,228,000 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
3.2%
|
2,000,000
|
$33,840,000 | — | 30 Sep 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3%
|
1,892,806
|
$32,026,278 | — | 30 Sep 2024 | |
| NVP Associates, LLC |
13F
|
Company |
2.9%
|
1,838,482
|
$31,107,115 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.5%
|
1,562,942
|
$26,444,979 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.4%
|
1,501,428
|
$24,802,166 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1.9%
|
1,183,260
|
$20,020,759 | — | 30 Sep 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.8%
|
1,158,000
|
$19,593,360 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
|
Company |
1.8%
|
1,150,000
|
$19,458,000 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.8%
|
1,144,035
|
$19,357,072 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.4%
|
878,667
|
$14,867,046 | — | 30 Sep 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
1%
|
650,695
|
$11,009,759 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
486,854
|
$8,238,000 | — | 30 Sep 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.47%
|
300,000
|
$5,076,000 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.3%
|
190,531
|
$3,223,785 | — | 30 Sep 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.24%
|
150,000
|
$2,538,000 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
150,000
|
$2,538,000 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
132,400
|
$2,240,208 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
117,381
|
$1,986,087 | — | 30 Sep 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.18%
|
111,605
|
$1,888,357 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
94,322
|
$1,595,928 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.12%
|
75,100
|
$1,270,692 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.12%
|
75,000
|
$1,269,000 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.09%
|
57,600
|
$974,592 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
51,050
|
$863,766 | — | 30 Sep 2024 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.06%
|
37,500
|
$634,500 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
32,299
|
$546,499 | — | 30 Sep 2024 | |
| Maven Securities LTD |
13F
|
Company |
0.05%
|
31,054
|
$525,434 | — | 30 Sep 2024 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.04%
|
27,880
|
$472,000 | — | 30 Sep 2024 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
0.04%
|
26,129
|
$442,103 | — | 30 Sep 2024 | |
| M&T BANK CORP |
13F
|
Company |
0.04%
|
24,884
|
$421,519 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
24,857
|
$420,580 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
15,500
|
$262,260 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
15,463
|
$261,000 | — | 30 Sep 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.02%
|
13,529
|
$228,911 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
13,000
|
$219,960 | — | 30 Sep 2024 | |
| Capula Management Ltd |
13F
|
Company |
0.02%
|
10,615
|
$179,606 | — | 30 Sep 2024 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.02%
|
10,074
|
$170,452 | — | 30 Sep 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
3,849
|
$65,125 | — | 30 Sep 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
3,762
|
$63,653 | — | 30 Sep 2024 | |
| Aster Capital Management (DIFC) Ltd |
13F
|
Company |
0%
|
3,018
|
$51,065 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
59
|
$998 | — | 30 Sep 2024 | |
| MRP Capital Investments, LLC |
13F
|
Company |
0%
|
35
|
$593 | — | 30 Sep 2024 | |
| Enavate Sciences GP, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,761,359
|
$63,943,103 | — | 16 Sep 2024 | |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
801,624
|
$13,627,608 | — | 16 Sep 2024 |
Institutional Holders of Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) as of Q4 2024
As of 31 Dec 2024,
Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,699,756 shares.
The largest 10 holders included
SR One Capital Management, LP, Enavate Sciences GP, LLC, NEA Management Company, LLC, Fairmount Funds Management LLC, NVP Associates, LLC, FMR LLC, Novo Holdings A/S, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vivo Capital, LLC, and FEDERATED HERMES, INC..
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
44
Q4 2024 holders
65
Holder diff
21
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.